Australia China Bioinnovation Roundtable 2025
Summary
The 2025 Australia China Bioinnovation Roundtable is a premier half-day forum designed to foster strategic collaboration between the Australian and Chinese life sciences sectors. Hosted by Boson Ventures and supported by the Australia China Business Council, Baker McKenzie, and Viva Biotech, this event will provide a timely and actionable dialogue on the evolving global biotechnology landscape.
Held at the offices of Baker McKenzie in Melbourne, the roundtable will focus on the immense opportunities for Australian innovators, startups, and research institutions to engage with China’s dynamic biotech ecosystem—from R&D partnerships and clinical trials to investment and market entry. The format is designed for maximum engagement, featuring expert panels, a moderated roundtable, and short, impactful presentations.
Why Attend?
Gain Strategic Insights: Understand the latest trends, regulatory shifts, and partnership models in China's biotech sector.
Connect with Key Players: Network with a curated audience of senior executives, investors, founders, and legal experts from Australia and China.
Identify Opportunities: Participate in a closed-door roundtable discussion to address challenges and uncover new avenues for growth.
2025澳中生物创新圆桌会议 · 上海-墨尔本双城联动
由波色创投主办，并获得LaunchVic与澳中工商业委员会（ACBC）支持，本届圆桌将首次实现上海医学界总部与墨尔本主会场实时互动，搭建跨越半球的创新对话平台。
会议聚焦精准对接澳中生物科技核心资源，汇聚政府决策者、产业领袖、顶尖科研机构与投资人，共同探讨从科研到商业化的全链条合作机遇。